|
Darunavir Impurity A
|
地瑞那韦杂质A
|
169280-56-2
|
|
Erlotinib Impurity 26
|
厄洛替尼杂质26
|
3943-89-3
|
|
Desoximetasone Impurity E
|
醋酸地塞米松EP杂质E
|
1524-94-3
|
|
Ezetimibe Impurity M
|
依折麦布杂质M
|
|
|
Erlotinib-d6 HCl
|
厄洛替尼杂质
|
1189953-78-3
|
|
Erlotinib Hydrochloride iMpurity 15
|
厄洛替尼杂质15
|
|
|
Febuxostat Impurity 26;3-cyano-4-isobutoxybenzoic acid
|
非布索坦杂质26
|
1886961-39-2
|
|
Febuxostat Impurity 27;3-cyano-4-isobutoxybenzamide
|
非布索坦杂质27
|
|
|
Dexamethasone EP Impurity F
|
地塞米松EP杂质F
|
382-67-2
|
|
Valsartan Methyl Ester
|
非布索坦杂质48
|
2375033-35-3
|
|
Erlotinib Impurity 1
|
厄洛替尼杂质1
|
2204518-92-1
|
|
Darunavir Impurity 19
|
地瑞那韦杂质
|
1402142-62-4
|
|
Febuxostat Impurity 46
|
非布司他杂质46
|
528607-60-5
|
|
Erlotinib O-Desmethyl Metabolite Isomer (M13) HCl
|
厄洛替尼杂质
|
183365-34-6
|
|
Desmethyl Erlotinib Carboxylate Acid
|
厄洛替尼杂质
|
1170354-84-3
|
|
DNV-II impurity 1
|
DNV-II杂质1
|
1005324-46-8
|
|
erythro-Hydroxy Bupropion HCl
|
安非他酮杂质
|
80478-43-9
|
|
Febuxostat Impurity 42
|
非布司他杂质42
|
100118-38-5
|
|
Febuxostat Impurity 45
|
非布司他杂质45
|
1229019-33-3
|
|
Captopril Impurity 1
|
卡托普利杂质1
|
119238-52-7
|
|
Erlotinib iMpurity 41
|
厄洛替尼杂质41
|
14235-81-5
|
|
Erlotinib Impurity 35
|
厄洛替尼杂质35
|
1839513-98-2
|
|
Rosuvastatin EP Impurity A
|
地屈孕酮杂质
|
25093-47-4
|
|
Erlotinib Impurity 30
|
厄洛替尼杂质30
|
183322-16-9
|
|
(R)-Amlodipine
|
醋酸地塞米松EP杂质F
|
2884-51-7
|
|
Darunavir-N-Glucuronide
|
达鲁那韦杂质
|
1159613-25-8
|
|
Erlotinib Impurity
|
厄洛替尼O-去甲基代谢物异构体（M14）HCl
|
183320-51-6
|
|
Erlotinib Impurity 45
|
厄洛替尼杂质45
|
183321-83-7
|
|
Erlotinib Impurity 1
|
厄洛替尼杂质
|
882420-22-6
|
|
Pitavastatin Impurity 54
|
匹伐他汀杂质54
|
1258947-30-6
|
|
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)
|
泊沙康唑对映异构体
|
|
|
Erlotinib Impurity 71
|
厄洛替尼杂质9
|
2055840-54-3
|
|
Erlotinib Impurity 46
|
厄洛替尼杂质46
|
938185-06-9
|
|
Febuxostat Impurity 41;4-hydroxybenzothioamide
|
非布索坦杂质41
|
|
|
Dexamethasone EP Impurity D
|
地塞米松EP杂质D
|
24916-90-3
|
|
Darunavir Impurity 2
|
地瑞那韦杂质2
|
1526916-57-3
|
|
Febuxostat Impurity 50;ethyl 2-(4-hydroxy-3-((hydroxyimino)methyl)phenyl)-4-methylthiazole-5-carboxylate
|
非布索坦杂质50
|
144060-84-4
|
|
Esomeprazole Impurity 25;2-(((3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-6-methoxy-1H-benzo[d]imidazole
|
埃索美拉唑杂质25
|
1080689-87-7
|
|
Desoximetasone Impurity C
|
醋酸地塞米松EP杂质C
|
|
|
Erlotinib iMpurity 40
|
厄洛替尼杂质40
|
|
|
Erlotinib Impurity 11
|
厄洛替尼代谢产物M11
|
882172-60-3
|
|
Erlotinib Impurity 66
|
厄洛替尼杂质66
|
1384975-87-4
|
|
Erlotinib Impurity 11
|
厄洛替尼杂质11
|
950596-59-5
|
|
Ezetimibe Impurity Q1;(S)-3-((2R,5R)-5-(4-fluorophenyl)-5-hydroxy-2-((S)-hydroxy(4-hydroxyphenyl)methyl)pentanoyl)-4-phenyloxazolidin-2-one
|
依折麦布杂质Q1
|
|
|
Esomeprazole Impurity 22
|
埃索美拉唑杂质22
|
|
|
Febuxostat Impurity 30;(Z)-ethyl 2-(3-((hydroxyimino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate
|
非布索坦杂质30
|
|
|
Febuxostat Impurity 37
|
非布索坦杂质46
|
2230270-05-8
|
|
Erlotinib Impurity 39
|
厄洛替尼杂质39
|
|
|
Darunavir Impurity 7 (S,S-Isomer)
|
达鲁那韦杂质7（S，S-异构体）
|
192800-79-6
|
|
Desoximetasone Impurity 16
|
地塞米松EP杂质16
|
2265-64-7
|
|
Desoximetasone Impurity 17
|
地塞米松甲磺酸钠
|
3936-02-5
|
|
Erlotinib Impurity 29
|
厄洛替尼杂质29
|
574738-66-2
|
|
DL-Folic Acid
|
叶酸杂质1
|
65165-92-6
|
|
DNV-II impurity 2
|
DNV-II杂质2
|
1133153-38-4
|
|
Febuxostat Impurity 30
|
非布司他杂质6
|
1271738-74-9
|
|
Febuxostat Impurity 44;ethyl 2-(3-formyl-2-hydroxyphenyl)-4-methylthiazole-5-carboxylate
|
非布索坦杂质44
|
|
|
Febuxostat Impurity 52
|
非布索坦杂质52
|
|
|
Dexamethasone-17-Ketone
|
地塞米松17-酮
|
2285-53-2
|
|
D-Folic Acid
|
叶酸杂质
|
65165-91-5
|
|
Febuxostat Impurity 52
|
非布司他杂质52
|
18962-07-7
|
|
Desoximetasone Impurity
|
地塞米松生物素
|
85679-56-7
|
|
Darunavir-O-Glucuronide
|
达鲁那韦杂质
|
1159613-27-0
|
|
Darunavir Impurity 9
|
达鲁那韦杂质8（R，R-异构体）
|
866594-61-8
|
|
Cilnidipine Impurity 27
|
地屈孕酮
|
152-62-5
|
|
Febuxostat Impurity 53;isobutyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate
|
非布索坦杂质53
|
1346238-13-8
|
|
Febuxostat Impurity 32;2-(4-hydroxy-3-((hydroxyimino)methyl)phenyl)-4-methylthiazole-5-carboxylic acid
|
非布索坦杂质32
|
1805770-41-5
|
|
Febuxostat Impurity 43;4-hydroxyisophthalonitrile
|
非布索坦杂质43
|
|
|
Febuxostat Impurity 47;2-(2-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid
|
非布索坦杂质47
|
|
|
Erlotinib impurity 70
|
厄洛替尼杂质67
|
1494468-76-6
|
|
D-Fudosteine
|
福多司坦
|
1023971-10-9
|
|
Didesmethyl Erlotinib
|
厄洛替尼杂质
|
183321-84-8
|
|
Darunavir-d9
|
地瑞那韦杂质
|
1133378-37-6
|
|
Erlotinib O-Desmethyl Metabolite Isomer (M13)
|
厄洛替尼杂质
|
183320-29-8
|
|
Ezetimibe Impurity Q2;(S)-3-((2R,5R)-5-(4-fluorophenyl)-5-hydroxy-2-((R)-hydroxy(4-hydroxyphenyl)methyl)pentanoyl)-4-phenyloxazolidin-2-one
|
依折麦布杂质Q2
|
|
|
Febuxostat Impurity 31;diethyl 2,2'-(4-hydroxy-5-(hydroxymethyl)-1,3-phenylene)bis(4-methylthiazole-5-carboxylate)
|
非布索坦杂质31
|
|
|
Febuxostat Impurity 82
|
非布索坦杂质45
|
2230270-03-6
|
|
D-Darunavir
|
地瑞那韦杂质
|
1399859-60-9
|
|
Tacrolimus Diene
|
去甲基他克莫司
|
132172-14-6
|
|
Erlotinib Impurity 67
|
厄洛替尼杂质44
|
183321-85-9
|
|
Erlotinib Hydrochloride iMpurity 14
|
厄洛替尼杂质14
|
|
|
Febuxostat Impurity 36;2-(3-cyano-4-ethoxyphenyl)-4-methylthiazole-5-carboxylic acid
|
非布索坦杂质36
|
1805770-40-4
|
|
Dexamethasone Sodium Phosphate EP Impurity H
|
地塞米松磷酸钠EP杂质H
|
162968-22-1
|
|
Desoximetasone Impurity
|
地塞米松17-甲酰氧基-17-酸
|
473273-04-0
|
|
3, 4-dihydroxybenzaldehyde
|
厄洛替尼杂质68
|
139-85-5
|
|
Tacrolimus EP Impurity E
|
他克莫司杂质
|
104987-30-6
|
|
Febuxostat Impurity 47
|
非布司他杂质47
|
161718-85-0
|
|
Erlotinib Impurity 68
|
厄洛替尼杂质A
|
183321-82-6
|
|
Febuxostat Impurity 46
|
非布司他杂质19
|
118485-48-6
|
|
Febuxostat iMpurity 20
|
非布索坦杂质20
|
|
|
Esomeprazole Impurity 23
|
埃索美拉唑杂质23
|
|
|
Dexamethasone Impurity G
|
地塞米松磷酸钠EP杂质G（地塞米松酸）
|
1597-78-0
|
|
Febuxostat Impurity 106
|
非布索坦杂质54
|
1346238-15-0
|
|
Febuxostat Impurity 49;ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
|
非布索坦杂质49
|
|
|
Noradrenaline Impurity 26
|
厄洛替尼
|
68304-21-3
|
|
Erlotinib Hydrochloride iMpurity 18
|
厄洛替尼杂质18
|
|
|
Ezetimibe Impurity R
|
依折麦布杂质R
|
|
|
Febuxostat Impurity 40;4-hydroxybenzonitrile
|
非布索坦杂质40
|
|
|
Esomeprazole Impurity 24
|
埃索美拉唑杂质24
|
|
|
Desoximetasone Impurity B
|
醋酸地塞米松EP杂质B
|
|
|
Desoximetasone Impurity
|
6-羟基地塞米松（非对映异构体混合物）
|
82778-08-3
|